metricas
Archivos de la Sociedad Española de Oftalmología (English Edition) Contact lenses as drug-delivery systems: a promising therapeutic tool
Journal Information
Vol. 95. Issue 1.
Pages 1-52 (January 2020)
Cite
Cite
Share
Download PDF
More article options
Visits
882
Vol. 95. Issue 1.
Pages 1-52 (January 2020)
Review

Contact lenses as drug-delivery systems: a promising therapeutic tool

Lentes de contacto para vehiculizar principios activos: una prometedora herramienta terapéutica
Visits
882
M.A. Holgado
Corresponding author
holgado@us.es

Corresponding author.
, A. Anguiano-Domínguez, L. Martín-Banderas
Departamento de Farmacia y Tecnología Farmacéutica, Facultad de Farmacia, Universidad de Sevilla, Sevilla, Spain
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Abstract

The ocular administration of drugs using traditional pharmaceutical forms, including eye drops or ointments, results in low bioavailability, as well as requiring multiple administrations per day, with the consequent danger of therapeutic non-compliance. Although, through the use of pharmaceutical technology, attempts have been made to use various solutions in order to increase bioavailability in the most common pharmaceutical forms, it has not been entirely satisfactory. In this context, contact lenses are presented as drug delivery systems that largely remedy these two major problems and offer other additional advantages. Therefore, the use of contact lenses as drug carrying systems has been increasingly investigated in recent years, as they can increase the bioavailability of these drugs, leading to an increase in therapeutic efficacy and compliance.

The main techniques used to achieve this goal are included in this review, including immersion in drug solutions, use of vitamin E barriers, molecular printing, colloidal systems, etc. The most interesting results, depending on the different eye pathologies, are presented.

Although the use of contact lenses as a vehicle for the release of active ingredients is a relatively novel strategy, there are already many studies and trials that support it. In any case, further research needs to be carried out to finally reach an effective, safe, and stable product that can be marketed.

Keywords:
Contact lenses
Ocular bioavailability
Controlled release
Eye diseases
Resumen

La administración ocular de fármacos utilizando formas farmacéuticas tradicionales, como las gotas oftálmicas o pomadas entre otras, proporciona una baja biodisponibilidad de los fármacos así como múltiples administraciones al día con el consiguiente peligro de incumplimiento terapéutico. Aunque la Tecnología Farmacéutica ha intentado proponer diversas soluciones para aumentar la biodisponibilidad en las formas farmacéuticas más comunes, no ha sido del todo satisfactorio. En este contexto, las lentes de contacto se presentan como sistemas de liberación de fármacos que subsanan en gran medida estos dos grandes problemas y ofrecen otras ventajas adicionales. Por ello, en los últimos años, se ha investigado con más empeño el uso de lentes de contacto como sistemas portadores de fármacos, ya que pueden aumentar la biodisponibilidad de los mismos, proporcionando un aumento de la eficacia y cumplimiento terapéuticos.

En la presente revisión se han referenciado las principales técnicas utilizadas para alcanzar dicho fin: inmersión en soluciones de fármaco, uso de barreras de vitamina E, impresión molecular, sistemas coloidales, etc. A continuación se recogen los resultados más interesantes encontrados en función de las distintas patologías oculares.

El uso de lentes de contacto para la vehiculización y liberación de principios activos es una estrategia relativamente novedosa aunque ya tiene muchos estudios y ensayos que lo sustentan. De todas formas se deben seguir investigando para alcanzar finalmente un producto eficaz, seguro y estable, y que pueda llegar a ser comercializado.

Palabras clave:
Lente de contacto
Biodisponibilidad ocular
Liberación controlada
Patologías oculares

Article

These are the options to access the full texts of the publication Archivos de la Sociedad Española de Oftalmología (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
References
[1]
J. Xu, Y. Xue, G. Hu, T. Lin, J. Gou, T. Yin, et al.
A comprehensive review on contact lens for ophthalmic drug delivery.
J Control Release, 281 (2018), pp. 97-118
[2]
I.M. Carvalho, C.S. Marques, R.S. Oliveira, P.B. Coelho, P.C. Costa, D.C. Ferreira.
Sustained drug release by contact lenses for glaucoma treatment. A review.
J Control Release, 202 (2015), pp. 76-82
[3]
F.A. Maulvi, T.G. Soni, D.O. Shah.
A review on therapeutic contact lenses for ocular drug delivery.
Drug Deliv, 23 (2016), pp. 3017-3026
[4]
P.W. Morrison, V.V. Khutoryanskiy.
Advances in ophthalmic drug delivery.
Ther Deliv, 5 (2014), pp. 1297-1315
[5]
A. Hui.
Contact lenses for ophthalmic drug delivery.
Clin Exp Optom, 100 (2017), pp. 494-512
[6]
S.W. Choi, J. Kim.
Therapeutic contact lenses with polymeric vehicles for ocular drug delivery: a review.
Materials, 11 (2018), pp. 1125
[7]
M. Dubald, S. Bourgeois, V. Andrieu, H. Fessi.
Ophthalmic drug delivery systems for antibiotherapy. A review.
Pharmaceutics, 10 (2018), pp. 10
[8]
I.D. Ruppenthal.
Drug-device combination approaches for delivery to the eye.
Curr Opin Pharmacol, 36 (2017), pp. 44-51
[9]
R. Garhwal, S.F. Shady, E.J. Ellis, J.Y. Ellis, C.D. Leahy, S.P. Mccarthy, et al.
Physiology and pharmacology sustained ocular delivery of ciprofloxacin using nanospheres and conventional contact lens materials.
Invest Ophthalmol Vis Sci, 53 (2012), pp. 1341-1352
[10]
M.F. Saettone, L. Salminen.
Ocular insert for topical delivery.
Adv Drug Deliver Rev, 16 (1995), pp. 95-106
[11]
A. ElShaer, S. Mustafa, M. Kasar, S. Thapa, B. Ghatora, R. Alany.
Nanoparticle-laden contact lens for controlled ocular delivery of prednisolone: formulation optimization using statistical experimental design.
Pharmaceutics, 8 (2016), pp. 14
[12]
J. Urda-Romacho, D. González-Vaquero, P. Acosta-Robles.
Insertos de hidroxipropilcelulosa en pacientes afectados con síndrome de ojo seco.
PAM, 42 (2018), pp. 387-391
[13]
Ficha técnica Lacrisert. [consultado 27 Mar 2019]. Disponible en https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/18771S12lbl.pdf.
[14]
K.P.S. Kumar, D. Bhowmik, G. Harish, S. Duraivel, B. Pragathi.
Ocular inserts : a novel controlled drug delivery system.
Pharma Innov, 1 (2013), pp. 1-16
[15]
H.J. Jung, A. Chauhan.
Ophthalmic drug delivery by contact lenses.
Expert Rev, 7 (2012), pp. 199-201
[16]
P. Dixon, C. Shafor, S. Gause, K.H. Hsu, K. Conrad, A. Chauhan.
Therapeutic contact lenses: a patent review.
Expert Opin Ther Pat, 25 (2015), pp. 1117-1129
[17]
A. Guzman-Aranguez, B. Colligris, J. Pintor.
Contact lenses: promising devices for ocular drug delivery.
J Ocul Pharmacol Th, 29 (2013), pp. 189-199
[18]
P. Dixon, C. Shafor, S. Gause, K. Hsu, C. Powell, A. Chauhan.
Therapeutic contact lenses: a patent review.
Expert Opin Ther Pat, 25 (2015), pp. 1117-1129
[19]
G. Behl, J. Iqbal, N.J. O’Reilly, P. McLoughlin, L. Fitzhenry.
Synthesis and characterization of poly(2-hydroxyethylmethacrylate) contact lenses containing chitosan nanoparticles as an ocular delivery system for dexamethasone sodium phosphate.
Pharm Res, 33 (2016), pp. 1638-1648
[20]
A. Patel, K. Cholkar, V. Agrahari, K.A. Mitra.
Ocular drug delivery systems: an overview.
World J Pharmacol, 2 (2013), pp. 47-64
[21]
A.M. Ribeiro, A. Figueiras, F. Veiga.
Improvements in topical ocular drug delivery systems: Hydrogels and contact lense.
J Pharm Pharm Sci, 18 (2015), pp. 683-695
[22]
J. Pintor.
Contact lenses: new devices for nucleotide delivery in ocular pathologies.
Purinergic Signal, 10 (2014), pp. 419-420
[23]
G. Qin, Z. Zhu, S. Li, A.M. McDermott, C. Cai.
Development of ciprofloxacin-loaded contact lenses using fluorous chemistry.
[24]
L. Bengani, K. Hsu, S. Gause, A. Chauhan.
Contact lenses as a platform for ocular drug delivery.
Expert Opin Drug Del, 10 (2013), pp. 1483-1496
[25]
C. Alvarez-Lorenzo, H. Hiratani, J.L. Gómez-Amoza, R. Martínez-Pacheco, C. Souto, A. Concheiro.
Soft contact lenses capable of sustained delivery of timolol.
J Pharm Sci, 91 (2002), pp. 2182-2192
[26]
P.B. Baranowski, M. Gajda, J. Pluta.
Ophthalmic drug dosage forms: characterisation and research methods.
[27]
H.J. Jung, A. Chauhan.
Temperature sensitive contact lenses for triggered ophthalmic drug delivery.
Biomaterials, 33 (2012), pp. 2289-2300
[28]
H.J. Jung, M. Abou-Jaoude, B.E. Carbia, C. Plummer, A. Chauhan.
Glaucoma therapy by extended release of timolol from nanoparticle loaded silicone-hydrogel contact lenses.
J Control Release, 165 (2013), pp. 82-89
[29]
F.M. Helaly, S.M. El-Sawy, A.I. Hashem, A.A. Khattab, R.M. Mourad.
Synthesis and characterization of nanosilver-silicone hydrogel composites for inhibition of bacteria growth.
Cont Lens Anterior Eye, 40 (2017), pp. 59-66
[30]
Q. Xu, S.P. Kambhampati, R.M. Kannan.
Ocular therapeutics of the future nanotechnology approaches for ocular drug delivery.
Middle East Afr J Ophthalmol, 20 (2013), pp. 26-37
[31]
S. Nayak, M. Jadhav, V. Bhaskar.
Recent advances in ocular drug delivery systems.
Research J Pharm Tech, 9 (2016), pp. 995-1006
[32]
H.J. Kim, K. Zhang, L. Moore, D. Ho.
Diamond nanogel-embedded contact lenses mediate lysozyme-dependent therapeutic release.
ACS Nano, 8 (2014), pp. 2998-3005
[33]
C. Álvarez-Lorenzo, S. Anguiano-Igea, A. Varela-García, M. Vivero-López, A. Concheiro.
Bioinspired hydrogels for drug-eluting contact lenses.
Acta Biomater, 84 (2019), pp. 49-62
[34]
C. Phan, H. Walther, H. Gao, J. Rossy, L.N. Subbaraman, L. Jones.
Development of an in vitro ocular platform to test contact lenses.
J Vis Exp, 110 (2016), pp. 53907
[35]
F.A. Maulvi, S.S. Singhania, A.R. Desai, M.R. Shukla, A.S. Tannk, K.M. Ranch.
Contact lenses with dual drug delivery for the treatment of bacterial conjunctivitis.
Int J Pharm, 548 (2018), pp. 139-150
[36]
J. Kim, C.C. Peng, A. Chauhan.
Extended release of dexamethasone from silicone-hydrogel contact lenses containing vitamin E.
J Control Release, 148 (2010), pp. 110-116
[37]
T. Katzer, P. Chaves, A. Pohlmann, S. Guterres, R.C.R. Beck.
Loading A drug on contact lenses using polymeric nanocapsules: effects on drug release, transparency, and ion permeability.
J Nanosci Nanotechnol, 17 (2017), pp. 9286-9294
[38]
D. Silva, L.F.V. Pinto, D. Bozukova, L.F. Santos, A.P. Serro, B. Saramago.
Chitosan/alginate based multilayers to control drug release from ophthalmic lens.
Colloids Surf B Biointerfaces, 147 (2016), pp. 81-89
[39]
Ficha técnica Ikervis® [consultada el 27 de marzo de 2019]. Disponible: https://cima.aemps.es/cima/pdfs/ft/115990001/FT_115990001.pdf.
[40]
C.C. Peng, A. Chauhan.
Extended cyclosporine delivery by silicone–hydrogel contact lenses.
J Control Release, 154 (2011), pp. 267-274
[41]
P. Dixon, T. Ghosh, K. Mondal, A. Konar, A. Chauhan, S. Hazra.
Controlled delivery of pirfenidone through vitamin E-loaded contact lens ameliorates corneal inflammation.
Drug Deliv Transl Res, 8 (2018), pp. 1114-1126
[42]
C. González-Chomón, M. Silva, A. Concheiro, C. Álvarez-Lorenzo.
Biomimetic contact lenses eluting olopatadine for allergic conjunctivitis.
Acta Biomater, 41 (2016), pp. 302-311
[43]
M.C. Phan, S. Weber, J. Mueller, A. Yee, L. Jones.
A rapid extraction method to quantify drug uptake in contact lenses.
Transl Vis Sci Technol, 2 (2018), pp. 11
[44]
A. Soluri, A. Hui, L. Jones.
Delivery of ketotifen fumarate by commercial contact lens materials.
Optometry Vision Sci, 89 (2012), pp. 1140-1149
[45]
K.H. Hsu, B.E. Carbia, C. Plummer, A. Chauhan.
Dual drug delivery from vitamin E loaded contact lenses for glaucoma therapy.
Eur J Pharm Biopharm, 94 (2015), pp. 312-321
[46]
E. Lavik, M. Kuehn, Y. Kwon.
Novel drug delivery systems for glaucoma.
Eye, 25 (2011), pp. 578-586
[47]
S. Mohammadi, L. Jones, M. Gorbet.
Extended latanoprost release from commercial contact lenses: in vitro studies using corneal models.
[48]
R.R. Horne, K.E. Judd, W.G. Pitt.
Rapid loading and prolonged release of latanoprost from a silicone hydrogel contact lens.
J Drug Deliv Sci Tec, 41 (2017), pp. 410-418
asdasdasd
Article options
Tools